Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.33% | 14.49% | 12.41% | 6.95% | -0.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.33% | 14.49% | 12.41% | 6.95% | -0.17% |
| Cost of Revenue | 8.41% | 2.45% | -2.99% | -8.66% | -15.55% |
| Gross Profit | 19.18% | 19.27% | 19.13% | 13.91% | 6.84% |
| SG&A Expenses | -26.68% | -33.73% | -39.58% | -23.70% | -6.24% |
| Depreciation & Amortization | -6.88% | 2.48% | 12.56% | 10.14% | 6.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.73% | -24.80% | -30.03% | -18.82% | -7.35% |
| Operating Income | 101.29% | 97.06% | 94.39% | 61.86% | 20.78% |
| Income Before Tax | 100.53% | 65.29% | 17.37% | -65.41% | -325.39% |
| Income Tax Expenses | -99.11% | 189.19% | 313.54% | 372.53% | 516.60% |
| Earnings from Continuing Operations | 100.25% | 50.66% | -53.73% | -180.20% | -608.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 100.25% | 50.66% | -53.73% | -180.20% | -608.03% |
| EBIT | 101.29% | 97.06% | 94.39% | 61.86% | 20.78% |
| EBITDA | 121.49% | 110.19% | 102.56% | 66.46% | 18.84% |
| EPS Basic | 100.19% | 50.50% | -54.17% | -182.01% | -623.90% |
| Normalized Basic EPS | 100.76% | 91.72% | 85.74% | 55.76% | 19.98% |
| EPS Diluted | 100.19% | 50.50% | -54.07% | -179.67% | -599.55% |
| Normalized Diluted EPS | 100.76% | 91.72% | 85.74% | 55.18% | 17.54% |
| Average Basic Shares Outstanding | 27.45% | 19.84% | 12.22% | 7.38% | 2.41% |
| Average Diluted Shares Outstanding | 30.46% | 22.85% | 15.24% | 6.91% | -1.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |